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Abstract
Background: Endothelin-1 (ET-1) inhibition of vasopressin (AVP)-stimulated water reabsorption
by the inner medullary collecting duct (IMCD) is associated with reduced cAMP accumulation. To
determine the effect of ET-1 deficiency, AVP-stimulated cAMP responsiveness was assessed in
IMCD from mice with collecting duct-specific deletion of ET-1 (CD ET-1 KO) and from control
animals.
Methods: Cyclic AMP production, adenylyl cyclase (AC) mRNA, and AC protein were measured
in acutely isolated IMCD.
Results: CD ET-1 KO IMCD had enhanced AVP-stimulated cAMP accumulation. Inhibition of
calcium-stimulated AC using BAPTA did not prevent enhanced AVP responsiveness in CD ET-1
KO IMCD. Factors known to be modified by ET-1, including nitric oxide, cyclooxygenase
metabolites, and superoxide did not affect the increased AVP responsiveness of CD ET-1 KO
IMCD. Differential V2 receptor or G-protein activity was not involved since CD ET-1 KO IMCD
had increased cAMP accumulation in response to forskolin and/or cholera toxin. CD ET-1 KO did
not affect mRNA or protein levels of AC3, one of the major known collecting duct AC isoforms.
However, the other known major collecting duct AC isoform (AC5/6) did have increased protein
levels in CD ET-1 KO IMCD, although AC5 (weak signal) and 6 mRNA levels were unchanged.
Conclusion: ET-1 deficiency increases IMCD AC5/6 content, an effect that may synergize with
acute ET-1 inhibition of AVP-stimulated cAMP accumulation.
Background
Endothelin-1 (ET-1) is likely to be an important regulator
of water reabsorption by the collecting duct. The majority
of studies done to date have utilized in vitro collecting
duct preparations; in these experiments, exogenous ET-1
consistently inhibits vasopressin (AVP) action. ET-1
reduces AVP-enhanced water flux in acutely isolated rat
cortical collecting tubules [1]. This effect is mediated, at
least in part, by protein kinase C (PKC)-sensitive inhibi-
tion of adenylyl cyclase activity and is independent of
dihydropyridine-type calcium channels and cyclooxygen-
ase metabolites [2,3]. ET-1 also inhibits AVP-stimulated
osmotic water permeability in in vitro perfused IMCD
[4,5]. Similar to the cortical collecting tubule, the ET-1
effect is likely through reduction of AVP-stimulated cAMP
accumulation [2,6]. Notably, ET-1 does not alter dibu-
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tyryl-cAMP-stimulated osmotic water permeability in the
IMCD [5], indicating that the inhibitory effect of ET-1 in
the IMCD is primarily due to reduction of adenylyl cyclase
activity. Also like the cortical collecting duct, ET-1 inhibi-
tion of cAMP accumulation in the IMCD is PKC-depend-
ent and is unrelated to cyclooxygenase or
dihydropyridine-type calcium channel activity [2,4,6]. In
addition, ET-1 acts through an inhibitory G protein since
pertussis toxin blocks the effects of ET-1 on AVP-stimu-
lated cAMP levels and water transport in IMCD [4,6].
Taken together, the above studies indicate that ET-1 is
capable of acutely reducing collecting duct water reab-
sorption through inhibiting adenylyl cyclase activity.
ET-1 may also chronically regulate collecting duct water
transport. Recent studies, using mice with collecting duct-
specific knockout of ET-1 (CD ET-1 KO), observed
reduced plasma AVP levels, enhanced AVP-stimulated
cAMP accumulation in acutely isolated IMCD, and
impaired ability to excrete an acute water load [7]. Thus,
chronic deletion of ET-1 in the collecting duct resulted in
increased sensitivity to the hydroosmotic and cAMP-stim-
ulating effects of AVP. Whether this effect is due to
reduced activity of signaling pathways implicated by acute
in vitro studies to mediate ET-1 inhibition of AVP action,
or if other mechanisms are involved, remains uncertain.
Hence, the aim of the current study was to examine the
mechanism(s) responsible for increased AVP sensitivity in
collecting ducts of CD ET-1 KO mice. We report that
chronic CD ET-1 deficiency results in increased AC5/6
protein content in IMCD.
Methods
Materials
Cholera toxin, pertussis toxin, BAPTA and tempol were
obtained from Calbiochem (San Diego, CA). All primary
antibodies directed against adenylyl cyclases were pur-
chased from Santa Cruz Biotechnology (Santa Cruz, CA).
Indomethacin, S-nitroso-N-acetylpenicillamine (SNP),
nitroprusside, monomethylarginine (L-NMMA) and all
other reagents were obtained from Sigma Chemical Co.
(St. Louis) unless specifically stated otherwise.
Transgenic mice
Mice with CD-specific disruption of the ET-1 gene were
generated as previously described [7]. Mice containing the
loxP-flanked (floxed) exon 2 of the ET-1 gene (obtained
from Dr. M. Yanagisawa at University of Texas Southwest-
ern) were mated with AQP2-Cre mice, the latter contain-
ing a transgene with 11 kb of the mouse AQP2 gene 5'-
flanking region driving expression of Cre recombinase, an
SV40 nuclear localization signal on the NH2 terminus of
Cre, and an 11-amino acid Herpes Simplex virus epitope
tag on the COOH terminus of Cre. Female AQP2-Cre mice
were mated with male floxed ET-1 mice; female offspring
heterozygous for both AQP2-Cre and floxed ET-1 were
bred with males homozygous for floxed ET-1. Animals
homozygous for floxed ET-1 and heterozygous for AQP2-
Cre (CD ET-1 KO) were used in all studies. Sex-matched
littermates that were homozygous for the floxed ET-1
gene, but without Cre, were used as controls in all studies.
Genotyping
Tail DNA was PCR amplified for the AQP2-Cre transgene
using oligonucleotide primers mAQP2 F (5'-CCTCT-
GCAGGAACTGGTGCTGG-3') and CreTag R (5'-GCGAA-
CATCTTCAGGTTCTGCGG-3'), which amplify the 671-bp
junction between the mouse AQP2 promoter and the Cre
gene. The ET-1 gene was amplified using three primer sets.
Primers ET-1CF (5'-GCTGCCCAAAGATTCTGAATTC-3')
and ET-1BR (5'-GATGATGTCCAGGTGGCAGAAG-3')
amplify 800 bp of the endogenous ET-1 allele. The prim-
ers ET-1AF (5'-CCCAAAGATTCTGAATTGATAACTTCG-3')
and ET-1BR (5'-GATGATGTCCAGGTGGCAGAAG-3')
amplify the same region, but the forward primer overlaps
loxP and only recognizes the floxed ET-1 allele. Primers
ET-1AF and ET-1DR (5'-AAC CTC CCA GTC CAT ACG
GTA C-3') amplify the region spanning the loxP sites; the
product of the non-recombined allele is 2 kb, while the
recombined product is 300 bp.
Acutely isolated IMCD preparations
Primary isolates of IMCD cells were obtained using a
modification of a previously described procedure [6].
Mice were sacrificed by cervical dislocation, the kidneys
removed, and the inner medulla minced and incubated in
0.1% collagenase (Type I; Worthington, Freehold, NJ)
containing 0.01% DNase (type I) in Hanks' balanced salts
solution (HBSS) supplemented with 15 mM HEPES (pH
7.4). Tissue digestion was carried out at 37°C in a shaking
water bath. When a suspension containing predomi-
nantly single cells and individual tubules was obtained
(approx. 45 min), the digest was filtered through a 74-μm-
mesh screen to remove any residual tissue. The tubule sus-
pension was centrifuged at 1500 rpm for 5 min, and the
cell pellet resuspended in 10% bovine serum albumin in
HBSS, followed by an additional 2 centrifuge/washes with
HBSS. The final pellet containing primarily tubules was
resuspended in HBSS/HEPES. This procedure has previ-
ously been shown to yield predominantly collecting ducts
[6]. All studies were done comparing control to CD ET-1
KO IMCD on the same day and under the same isolation
conditions.
Cell culture
Freshly isolated IMCD were grown in primary culture as
previously described [8]. The cell suspension was plated
in 24 well plates in Renal Epithelial Cell Growth Media
(Cambrex, Walkersville, MD) containing epidermal
growth factor, insulin, hydrocortisone, gentamicin,
amphotericin, 0.5% fetal bovine serum, epinephrine, trii-
odothyronine, and transferrin (concentrations are propri-
etary). Once cells reached confluence, the media was
changed to DMEM:F12 alone for 16–24 hr prior to study.BMC Nephrology 2007, 8:8 http://www.biomedcentral.com/1471-2369/8/8
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cAMP studies
Freshly isolated or cultured IMCD from floxed or CD ET-1
KO animals were pre-incubated in HBSS/HEPES buffer (pH
7.4) containing 1 mM 3-isobutyl-l-methylxanthine (IBMX)
for 30 min at 37°C, followed by addition of 100 pM AVP, 1
nM AVP or 1 μM forskolin for 10 min. In studies involving
additional treatments (inhibitors, etc), theses agents were
added to the incubation at the same time as the IBMX. At the
end of the incubations, cellular cAMP and total protein were
determined. cAMP was extracted from cells by addition of
70% ethanol overnight at -20°C. The sample was then cen-
trifuged and the ethanol removed from the cell pellet. The
ethanol was evaporated, the residual material resuspended
in assay buffer, and cAMP assayed using a commercial
enzyme immunoassay kit (Assay Design, Ann Arbor, MI).
The cell pellet (precipitated in ethanol) was re-dissolved in
0.1 N NaOH for determination of total cellular protein by
the Bradford assay.
Western analysis of adenylyl cyclases
IMCD were prepared as above, solubilized in Laemmli
buffer containing 0.5% lithium dodecyl sulfate, and soni-
cated to reduce viscosity. Samples were run on a denaturing
NUPAGE 4–12% Bis-Tris mini-gel using a MOPS buffer sys-
tem (Invitrogen, Carlsbad, CA). Proteins were transferred to
PVDF plus nylon membrane by electroelution and visual-
ized using the Adance ECL system (GE Healthcare Piscata-
way, NJ). Protein loading was normalized to β-actin.
Densitometry was done using a BioRad gel documentation
system (Hercules, CA).
Anti-adenylyl cyclase antibodies used for immunoblotting
were incubated with membranes in blocking buffer (5%
milk-TBST) overnight at 4°C at concentrations from
1:25,000–1:100,000. Secondary donkey anti-rabbit horse-
radish peroxidase-conjugated antibody (GE Healthcare, Pis-
cataway, NJ) was incubated at room temperature in blocking
buffer. After visualization, blots were stripped and incubated
with anti-β-actin antibody (Abcam, Cambridge, MA) at
1:10,000 in blocking buffer, then exposed to secondary anti-
body as above.
RT-PCR of adenylyl cyclase mRNA
Total RNA was prepared from isolated IMCD using acid phe-
nol, and potentially contaminating genomic DNA removed
by incubation with RNase-free DNase I (Promega, Madison,
WI). Reverse transcription was performed on 3 μg total RNA
using oligo (dT)12–18 and Superscript II according to the
manufacturer's protocol (Invitrogen Carlsbad, CA). PCR
primers were designed from mouse cDNA sequences to span
an intron in order to distinguish genomic contamination.
PCR amplification was performed using Taq polymerase
(Invitrogen). All products were sequenced to insure fidelity
of amplification. Primers used were: AC3 F5'-GCAGCACCT-
GGCTGACCTGGCTGA-3' and R5'-TGGGGCAGTGTAACA-
GAGGAGCCA-3' which yields a 383 bp product; AC5 – F5'-
CAATACAGTGAATGTGGCCAGCCG-3' and R5'-TTCCCTT-
ACAGGGCATTGTCTCTG-3' product which yields a 363 bp
product; AC6 -F5'-GATTCCGGCAGTTGGAGAAGATCA-3'
and R5'-TCCCACTCAATGCCCACCTTGGTC-3' product
which yields a 494 bp product; and GAPDH – F5'-CCT-
TCATTGACCTCAACTACATGG-3 and R5'-GCAGTGAT-
GGCATGGACTGTGGT-3' which yields a 442 bp product.
Gels were stained with ethidium bromide and mRNA con-
tent determined by densitometry. All results were normal-
ized to GAPDH.
Statistics
Comparisons of cAMP accumulation or adenylyl cyclase
mRNA or protein between CD ET-1 KO and floxed mice
for a given condition, or between AVP and AVP + inhibitor
in floxed mice, were made by the unpaired Student's t-test.
p < 0.05 was taken as significant. Data are expressed as
mean ± SEM.
Results
Acutely isolated mouse IMCD accumulate detectable
cAMP only in the presence of phosphodiesterase inhibi-
tion; consequently, all studies were done in the presence
of IBMX. No cAMP was detectable in the absence of ago-
nists or in the presence of vehicle for drugs alone. AVP was
added at a concentration of 1 nM for 10 minutes since this
regimen has previously been determined to cause half-
maximal stimulation of cAMP accumulation in IMCD
from floxed and CD ET-1 KO animals [7]. Forskolin was
used at a maximal cAMP stimulatory concentration of 1
μM [7]. Tubules were exposed to IMBX and various inhib-
itors/reagents for 30 minutes before addition of AVP or
forskolin -incubation of acutely isolated IMCD for longer
periods led to reduced AVP or forskolin sensitivity, pre-
sumably due to decreased viability of acutely isolated cells
in suspension. Thus, while failure of inhibitors to exert an
observable effect on AVP or forskolin responsiveness
might be attributed to the length of exposure to the cells,
these were the only workable conditions. Notably, pri-
mary cultures of mouse IMCD have markedly decreased
AVP-stimulated cAMP accumulation, and the difference
in AVP, as well as forskolin, responsiveness between
floxed and CD ET-1 KO mice was lost (1 μM forskolin: CD
ET-1 KO 6.91 ± 1.00 vs. control 6.38 ± 1.8 nmol cAMP/μg
total cell protein; 100 nM AVP: CD ET-1 KO 0.94 ± .35 vs.
control 1.71 ± 0.81 nmol cAMP/μg total cell protein).
Hence, only acutely isolated preparations were studied. It
should also be noted that 100 pM AVP also caused
enhanced CD ET-1 KO cAMP accumulation (157 ± 9% of
control values, n = 15, p < 0.001). In addition, results
using 1 nM AVP are described below, however similar
results were obtained using 100 pM AVP (data not
shown).
IMCD from CD ET-1 KO, as compared to floxed, mice had
approximately 40% greater cAMP accumulation in
response to AVP, as previously reported [7]. Inhibition of
NOS with NMMA, or addition of SNP or NTP, at concen-BMC Nephrology 2007, 8:8 http://www.biomedcentral.com/1471-2369/8/8
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trations previously shown to inhibit IMCD NO produc-
tion or to increase IMCD cGMP content, respectively [9],
did not alter AVP-stimulated cAMP accumulation in CD
ET-1 KO IMCD or floxed controls (Figure 1). Tempol, at a
concentration shown to prevent superoxide production in
collecting duct (5 mM) [10], did not affect AVP respon-
siveness in IMCD from either group of animals (Figure 1).
Indomethacin, at a concentration shown to inhibit PGE2
production in IMCD (10 μM) [6], did not alter AVP-aug-
mented cAMP content in CD ET-1 KO or floxed IMCD
(Figure 1). Thus, inhibition of NO, superoxide and or
prostaglandin formation did not affect AVP-stimulated
cAMP accumulation.
Augmented cAMP levels persisted in IMCD from CD ET-1
KO IMCD treated with either pertussis or cholera toxin
(172 ± 18% and 142 ± 6%, respectively, of similarly
treated floxed IMCD) (Figure 2), indicating that the
enhanced AVP responsiveness in CD ET-1 KO IMCD is
not due to alterations in the V2 receptor or G proteins.
Further evidence of this was the finding that 1 μM forsko-
lin increased cAMP accumulation in CD ET-1 KO IMCD
165 ± 11% (n = 19, p < 0.001) as compared to control
IMCD (Figure 2), in agreement with previous findings [7].
Even combining forskolin with cholera toxin, which
caused a 40-fold increase in cAMP levels over that seen
with AVP alone, resulted in enhanced CD ET-1 KO cAMP
levels (142 ± 10% of controls, n = 8, p < 0.05) (Figure 2).
Chelation of intracellular calcium with BAPTA reduced
AVP-stimulated cAMP accumulation, however it failed to
prevent enhanced AVP responsiveness in CD ET-1 KO
mice (Figure 1). Of the three known calcium-stimulated
adenylyl cyclases (1, 3 and 8), IMCD express primarily
AC3 mRNA [11]. There was no difference in AC3 protein
between CD ET-1 KO and floxed IMCD (Figure 3); simi-
larly, the total AC3 mRNA levels were not different
between IMCD from the two groups (Figure 4). Thus, cal-
cium – dependent adenylyl cyclase activity, which most
likely reflects AC3 activity, does not account for enhanced
AVP responsiveness in CD ET-1 KO IMCD.
The failure to see an effect of acute inhibitor exposure on
the enhanced AVP responsiveness of CD ET-1 KO IMCD
suggested that the total amount of one or more adenylyl
cyclases may be increased in these cells. Using Western
analysis, we were only able to detect AC3 (as stated above)
and AC5/6 (the only antibody available to us can not dis-
tinguish between AC5 and AC6) protein. Notably, AC5/6
protein was significantly increased in IMCD from CD ET-
1 KO mice (130% of floxed controls) (Figure 3). PCR of
IMCD revealed a faint signal for AC5 (data not shown)
and a relatively strong signal for AC6 (Figure 4). However,
CD ET-1 KO mice did not have significantly different AC6
mRNA content (Figure 4).
Discussion
Collecting duct-specific deficiency of ET-1 is associated
with reduced plasma AVP levels and impaired ability to
excrete an acute water load [7]. This effect is due, at least
in part, to enhanced AVP-stimulated cAMP accumulation
in ET-1-deficient IMCD. In the current study, we found
that acute blockade of nitric oxide synthase, superoxide
Effect of 1 μM forskolin, 1 μg/ml cholera toxin, or both  agents together on cAMP accumulation in acutely isolated  IMCD from CD ET-1 KO and floxed (control) mice Figure 2
Effect of 1 μM forskolin, 1 μg/ml cholera toxin, or both 
agents together on cAMP accumulation in acutely isolated 
IMCD from CD ET-1 KO and floxed (control) mice. All data 
are expressed as percent of cAMP accumulation with forsko-
lin alone in control IMCD. Control IMCD forskolin-stimu-
lated cAMP accumulation was 497 ± 32 fmol cAMP/μg total 
cell protein (n = 15). *p < 0.05 compared to floxed controls 
treated with the same condition; **p < 0.005 vs. forskolin 
alone in control IMCD. N = 5–10 each data point.
*
*
*
**
**
Effect of 100 μM NMMA, 1 mM SNAP (SNP), 1 mM nitro- prusside (NTP), 5 mM tempol, 10 μM indomethacin (Indo),  or 1 μM BAPTA on AVP (1 nM) – stimulated cAMP accumu- lation in acutely isolated IMCD from CD ET-1 KO and floxed  (control) mice Figure 1
Effect of 100 μM NMMA, 1 mM SNAP (SNP), 1 mM nitro-
prusside (NTP), 5 mM tempol, 10 μM indomethacin (Indo), 
or 1 μM BAPTA on AVP (1 nM) – stimulated cAMP accumu-
lation in acutely isolated IMCD from CD ET-1 KO and floxed 
(control) mice. All data are expressed as percent of cAMP 
accumulation with AVP alone in control IMCD. Control 
IMCD AVP-stimulated cAMP accumulation was 141 ± 9 fmol 
cAMP/μg total cell protein (n = 18). *p < 0.05 compared to 
floxed controls treated with the same condition, **p < 0.01 
vs. control + no inhibitor. N = 6–18 each data point.
* *
*
* *
*
*
**BMC Nephrology 2007, 8:8 http://www.biomedcentral.com/1471-2369/8/8
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formation, cyclooxygenase, or intracellular calcium failed
to prevent the exaggerated AVP responsiveness in CD ET-
1 KO mice. These observations suggested that there might
be an absolute increase in adenylyl cyclase protein con-
tent. Indeed, CD ET-1 KO caused an increase in adenylyl
cyclase 5/6 protein content, and this increase was of a
magnitude comparable to that seen for increased AVP-
stimulated cAMP levels (CD ET-1 KO IMCD have approx-
imately a 40% greater AVP-stimulated cAMP content and
30% greater AC5/6 levels as compared to floxed controls).
Thus, chronic deficiency of ET-1 in the collecting duct
increases adenylyl cyclase protein; taken together with the
known acute inhibitory effect of ET-1 on AVP-stimulated
cAMP accumulation, these results suggest that collecting
duct-derived ET-1 may exert a diuretic effect through both
acute modulation of adenylyl cyclase activity and chronic
down-regulation of adenylyl cyclase protein content.
The mechanism(s) by which ET-1 deficiency leads to ele-
vated adenylyl cyclase levels are unknown. We detected a
faint signal for AC5 mRNA and a much stronger signal for
AC6. Such findings are in agreement with two previous
studies wherein AC6 mRNA was strongly present in rat
IMCD, but AC5 mRNA was undetectable [12,13]. Another
study found that rat collecting duct principal cells
expressed AC6, but not AC5 mRNA, while intercalated
cells expressed message for both isoforms [14]. Thus,
while our Western analysis is not conclusive, taken
together with the apparently very low AC5 mRNA signal
in mouse IMCD, and essentially no AC5 mRNA in rat
IMCD, the data suggest that AC6 is the predominant iso-
form undergoing ET-1 regulation. Interestingly, no
change in AC6 mRNA was identified in CD ET-1 KO mice.
This could represent translational regulation of AC6
mRNA, increased trafficking of AC6 to the membrane, or
reduced metabolism of AC6 protein. Another possibility
is that the changes in AC6 mRNA that would account for
a 30% increase in AC6 protein would be very difficult to
detect. It is worth noting, however, that there is precedent
for changes in AC6 content in IMCD – Hoffert and col-
leagues have reported a 5-fold decrease in AC6 protein
abundance in inner medulla from Brattleboro rats given
dDAVP as compared to saline alone [11]. Finally, the sig-
naling pathways by which ET-1 modulates adenylyl
cyclase protein content are unknown; determine of these
regulatory systems is in need of further investigation.
In this study, forskolin stimulated cAMP accumulation in
IMCD, however CD ET-1 KO IMCD had greater sensitivity
to forskolin than did control IMCD, in agreement with
previous observations [7]. Cholera toxin augmentation of
cAMP levels was also greater in IMCD from CD ET-1 KO
RT-PCR analysis of adenylyl cyclases 3 (AC3) and 6 (AC6) in  floxed control and CD ET-1 KO IMCD Figure 4
RT-PCR analysis of adenylyl cyclases 3 (AC3) and 6 (AC6) in 
floxed control and CD ET-1 KO IMCD. All results were nor-
malized to GAPDH. A representative blot is shown (n = 5 
total).
AC3
AC6
GAPDH
Control ET-1 KO
Western analysis of adenylyl cyclases 3 (AC3) and 5/6(AC5/ 6) in floxed control and CD ET-1 KO IMCD Figure 3
Western analysis of adenylyl cyclases 3 (AC3) and 5/6(AC5/
6) in floxed control and CD ET-1 KO IMCD. All results were 
normalized to β-actin. Upper panel shows representative 
blot (n = 8 total). Bottom panel shows densitometry analysis. 
*p < 0.05 CD ET-1 KO IMCD AC protein content as com-
pared to that observed in floxed controls.BMC Nephrology 2007, 8:8 http://www.biomedcentral.com/1471-2369/8/8
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mice. When cAMP accumulation was maximally and mas-
sively stimulated by combining cholera toxin and forsko-
lin, IMCD from CD ET-1 KO still exhibited greater AC
responsiveness. Notably, the percent of enhanced respon-
siveness in CD ET-1 KO IMCD was similar in AVP- and
forskolin/cholera toxin-treated cells. Taken together, these
data strongly suggest that neither the V2 receptor nor G-
proteins can account for the increased cAMP levels in CD
ET-1 KO mice, supporting a primary change in AC activity
per se.
Finally, the question must be raised as to whether ET-1
regulates mouse collecting duct water transport in a man-
ner similar to that described in other species. Relatively
few studies have examined ET-1 actions in mouse collect-
ing duct, perhaps due to technical difficulties. We did
observe in our study on water transport in CD ET-1 KO
mice [7] that absence of CD ET-1 caused a reduced ability
to excrete an acute water load associated with increased
urine osmolality. Notably, and as in other species, ET-1
increased intracellular calcium concentration in mouse
Ml CCD cells by stimulating both release from intracellu-
lar stores as well as nifedipine-sensitive calcium entry
[15]. Similarly, Naruse and colleagues found that ET-1
increased intracellular calcium concentration in super-
fused mouse CCD, OMCD, and IMCD. Taken together
with the findings in the current study, these investigations
strongly suggest that mouse collecting function, including
water transport, is regulated by ET-1.
Conclusion
Collecting duct-specific deletion of ET-1 is associated with
an increase in most likely AC6 protein abundance. This
increase in AC6 is associated with a comparable degree of
increase in collecting duct AVP-stimulated cAMP accumu-
lation. Thus, ET-1 may be capable of both acute and
chronic inhibition of collecting duct AVP responsiveness.
Such a system may be important in the regulation of col-
lecting duct water reabsorption, particularly under water
diuresis conditions wherein elevated collecting duct ET-1
may facilitate net renal water excretion.
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